Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03997968
Title A Phase 1/2 Study of CYT-0851, an Oral RAD51 Inhibitor, in B-Cell Malignancies and Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Cyteir Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Francisco San Francisco California 94158 United States Details
Stanford Comprehensive Cancer Center Stanford California 94305 United States Details
Sarah Cannon Research Institute at HealthONE Denver Colorado 80218 United States Details
Florida Cancer Specialists and Research Institute Sarasota Florida 34232 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02115 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
John Theurer Cancer Center at HUMC Hackensack New Jersey 07601 United States Details
NYU Langone Health New York New York 10016 United States Details
Oklahoma University-Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
Thomas Jefferson University, Sidney Kimmel Cancer Center Philadelphia Pennsylvania 19107 United States Details
Sarah Cannon Research Institute at Tennessee Oncology Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Washington Seattle Cancer Center Seattle Washington 98109 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field